IPO Weekly Recap: Biofrontera shines in debut

Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and long term risks of the new companies….. A full-service firm!

This past week two IPOs debuted that came with contrasting debuts.

Screen Shot 2018-02-16 at 4.22.34 PM

Of the two deals that came to market, one was a hold-over from the previous week and the other was a biotech offering that currently trades on the Frankfurt Stock Exchange.

BiofronteraAG

The Biofrontera AG (BFRA) was underwritten by Benchmark and priced 1.2mm ADSs at $9.88. The deal opened at $13.00 and traded very well in its opening week as the offering hit new highs above $14.00 in its third session on Friday. BFRA closed at $14.23 for a gain of 44.0% for investors who held through Friday.

MotusGiMotus GI Holdings (MOTS) priced 3.5mm shares at the low-end of the range, $5.00, and opened flat. MOTS broke its offering price immediately and traded below issue for the rest of the week. MOTS closed at $4.00 for a 20% loss.

Farmmi

Microcap Farmmi Inc (FAMI) priced 1.68mm shares at $4.00. The company processes and sells four categories of agricultural products: Shiitake mushrooms, Mu Er mushrooms, other edible fungi, and other agricultural products. The company experienced several volatility halts but opened Friday at $4.40 and traded to a Friday close of $6.18 for a gain of 54.5% as of the close Friday.

IPO Weekly Recap: Biofrontera shines in debut
Scroll to top
error: Content is protected !!